Introduction
The ability to transfect neuronal cells efficiently and safely could provide a powerful tool for the elucidation of neuronal function and may lead to novel treatments for neurological disorders. Gene therapy for the CNS has been hampered by the lack of efficient means for transducing post-mitotic neurons. Most studies have utilised viral vectors for gene delivery. However, many viral vectors are plagued by problems of immunity and cytotoxicity and are not easily manipulated by nonvirologists. [1] [2] [3] Nonviral vectors are now emerging as an alternative method of cellular transduction. The most promising advances in nonviral gene transfer have been in the production of synthetic liposomes formulated with cationic lipids (cytofectins) able to transfect cells. Such cationic liposomes are relatively easy to use, have a broad applicability and lack cytotoxicity. were able to transfect an undifferentiated neuronal ND7 cell line with ␤-galactosidase reporter gene five-fold more effectively than lipoplex mixtures prepared from pCMV␤ plasmid and DC-Chol/DOPE cationic liposomes. Mu was found to give an identical enhancement to cationic liposomemediated transfection of ND7 cells as poly-L-lysine (pLL) or protamine sulfate (PA). The enhancing effects of mu were found to be even greater (six-to 10-fold) when differentiated ND7 cells were transfected with mu-containing lipopolyplex mixtures. Differentiated ND7 cells represent a simple ex vivo-like post-mitotic CNS cell system. Successful transfection of these cells bodes well for transfection of primary neurons and CNS cells in vivo. These findings have implications for experimental and therapeutic uses of cationic liposomemediated delivery of nucleic acids to CNS cells. Gene Therapy (2001) 8, 453-460.
Novel cationic liposome formulations are constantly being developed. 5 However, few of these complexes have been examined for their ability to transduce cells within the CNS efficiently. [6] [7] [8] [9] Cationic liposomes act via electrostatic interactions with negatively charged nucleic acids and subsequently are taken across the cell membrane by a process of slow endocytosis. 6, 10, 11 Once inside, a proportion of the bound nucleic acids dissociates and escapes from early endosomes into the cytoplasm either to perform a function there in the case of mRNA, or else traffic into the nucleus as in the case of DNA. Frequently, cationic liposomes are formulated with the neutral lipid dioleoyl-L-␣-phosphatidylethanolamine (DOPE) that is thought to assist in endosome disruption. 8, 12 Indeed, one of the main cationic liposome systems shown to mediate successful transfection in the CNS is formulated from DOPE and the cytofectin N- [1-(2,3-dioleyloxy) propyl]-N,N,N trimethyl ammonium chloride (DOTMA). [13] [14] [15] [16] Recently, there have been attempts to enhance or improve upon cationic liposome-mediated transfection by precondensation of nucleic acids with a number of different possible polycationic agents leading to some improved transfection efficiencies. [17] [18] [19] [20] [21] [22] [23] Various polyca-tions have been identified which are efficient at enhancing cationic liposome-mediated transfection. Of these, poly-l-lysine (pLL) and protamine sulfate (PA) have proven the most effective to date, enabling increases in transfection of sometimes over 30-fold compared with cationic liposome-mediated transfection, in a variety of non-neuronal cell lines. 17, 21 Fritz et al 22 have described increases in cationic liposome-mediated transfection using a recombinant human H1 histone protein incorporating a nuclear localisation signal (NLS-H1). In addition, the nonhistone chromosomal high mobility group 1,2 (HMG-1,2) proteins have been used with some effect as part of HVJ liposome systems. 20, 24 Protamine is a naturally occurring polycation found in the head of spermatozoa. The role of protamine is to condense DNA in sperm and aid in its transfer to the egg nucleus. This nuclear localising property of protamine makes it particularly attractive for transfection applications. Also, protamine sulfate is a smaller defined peptide system (4-4.25 kDa), as compared with pLL that embraces a range of average chain lengths and molecular weights (typically 18-19.2 kDa). Smaller polycationic agents such as protamine would be expected to show less likelihood of immunogenic responses in the target tissue and nucleic acid condensation should be easier to control. For this reason, we have been exploring the possibility that other small cationic peptides may be enhancers of cationic liposome-mediated transfection. To this end we have begun examining peptides and proteins closely associated with virus DNA. Here we report the results of studies carried out with two cationic peptides, (mu) and Vp1. Vp1 is a 19 amino acid residue cationic peptide and the only structural peptide of polyomavirus to exhibit DNA binding properties. 25, 26 Mu is a 19 amino acid residue polycationic peptide known to be associated with the core complex of adenovirus (Table 1) . 27, 28 Vp1 but not mu contains an embedded classical nuclear localisation signal (NLS) similar to that found in HMG-1,2 and NLS-H1. 22, 26 We found that mu showed promising transfection enhancing properties even with differentiated, postmitotic neuronal cells indicating the possible usefulness of this peptide for future in vivo applications.
Results

DNA binding analysis
The capacity of mu to bind plasmid DNA (pDNA) was studied by gel retardation assay. This was compared directly with the capacity of Vp1. The pDNA used throughout was pCMV␤ that expresses a ␤-galactosidase reporter gene. Varying amounts of both peptides were incubated with pCMV␤ at room temperature for approxi- Gly-Gly-OH 2049 5 NH 2 -Met-Ala-Pro-Lys-Arg-Lys-Ser-Gly-Val-Ser-Lys-Cys-Glu-Thr-Lys-Cys-Thr-ProPro-OH The NLS sequence in VP1 is underlined. mately 20 min and then analysed by agarose gel electrophoresis. Without the addition of peptide, supercoiled and relaxed circular pCMV␤ migrated in the expected manner (Figure 1b, c; lane 8 ). Beginning at a pCMV␤:mu ratio of 1:0.25 (w/w) the migration of pCMV␤ was slightly affected, but at a ratio 1:0.5 (w/w) the migration of pCMV␤ was substantially retarded. At ratios above 1:0.5 pCMV␤ was unable to migrate into the agarose gel at all and the ability of ethidium bromide to interchelate pCMV␤ was significantly reduced. By contrast, Vp1 was unable to retard or otherwise affect pCMV␤ up to a pCMV␤:Vp1 ratio of 1:32 (w/w) ( Figure 1 ).
Transfection of undifferentiated ND7 cell line Previously, cationic liposomes formulated from 3␤-[N-(NЈ,NЈ-dimethylaminoethane)-carbamoyl]cholesterol (DC-Chol) and DOPE were shown to be able to transfect ND7 cells efficiently, a neuronally derived cell line. 29 Transfection was optimal (Ͼ40% of cells) using lipoplex mixtures prepared from pDNA (1 g) complexed with DC-Chol/DOPE (3 g). 29 Typically, maximal levels of transgene expression were obtained between 48-60 h after transfection during which time significant numbers of cell divisions had almost certainly taken place. In the studies described here, transfection of ND7 cells with lipoplex mixtures (pCMV␤:(DC-Chol/DOPE) ratio 1:3, 1:4, or 1:6 (w/w)) was compared with transfection involving lipopolyplex mixtures prepared by combining various quantities of mu with pCMV␤ (1 g) and DCChol/DOPE cationic liposomes ( Figure 2 ). Enzyme assays were performed 20-24 h after transfection for convenience (data trends were found to be unaffected by this shorter period of post-transfection cell growth). Results from the gel retardation assay suggested that at a pCMV␤:mu ratio of 1:0.5 (w/w), sufficient mu to neutralise and sequester all pCMV␤ was present ( Figure 1 ). However, lipopolyplex mixtures prepared with this pCMV␤:mu ratio were no more effective at mediating transfection than corresponding DC-Chol/DOPE lipoplex mixtures prepared with the same amount of pCMV␤ (results not shown). Therefore, we prepared a series of lipopolyplex mixtures with 0.6, 6, 12 or 21 g of mu so as to investigate the consequences of using larger quantities of mu. Several lipopolyplex mixtures were found to perform better than DC-Chol/DOPE lipoplex mixtures. The most effective was pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w). This combination was five-fold more effective at mediating transfection than the best DC-Chol/DOPE lipoplex mixture (pCMV␤:(DC-Chol/DOPE) 1:3 (w/w)) and 11-fold better than pCMV␤ alone ( Figure 2 ). By contrast, pCMV␤:mu polyplex mixtures failed to transfect cells more effectively than pCMV␤ alone. Gratifyingly, there was no obvious cell loss detected with any of the lipopolyplex mixtures used. Also, the concentration of protein in the cellular lysates used for ␤-galactosidase reporter gene assays did not significantly vary with nontransfected cells (data not shown). ND7 transfection experiments performed with Vp1-containing lipopoly- Gene Therapy plex mixtures failed to provide any improvement over lipoplex transfection levels. Finally, parallel experiments were carried out with COS7 cells. Using this cell line, pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w) lipopolyplex mixtures were found to be the most effective at mediating transfection once again, being four-fold more effective than the best DC-Chol/DOPE lipoplex mixtures (pCMV␤:(DC-Chol/DOPE) 1:6 (w/w)) (data not shown). The ␤-galactosidase reporter gene assay provides a measure of the overall level of ␤-galactosidase produced, but gives no information regarding the number of cells transfected. For this reason, we also performed cell counts on transfected ND7 cells. Cells were transfected with pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w) lipopolyplex mixtures and a six-fold increase in the number of ␤-galactosidase positive cells was observed compared with transfection mediated by pCMV␤:(DC-Chol/DOPE) 1:3 (w/w) lipoplex mixtures (Figures 3 and 5) . A direct comparison was made between lipopolyplex mixtures formulated with mu and mixtures formulated with poly-l-lysine (pLL) and protamine (PA) sulfate. Both pLL and protamine sulfate have been shown to enhance liposome-mediated transfection in other cell types, [17] [18] [19] but to the best of our knowledge neither have been utilised for the transfection of neuronal cells. Lipopolyplexes of pLL or PA were prepared with a variety of component ratios based upon reported results with other cultured cell lines. 21 In the event, both pLL and PA containing lipopolyplex mixtures were also found to outperform DC-Chol/DOPE lipoplex mixtures, the most effective being pCMV␤:pLL:(DC-Chol/DOPE) 1:2:6 (w/w/w) and pCMV␤:PA:(DC-Chol/DOPE) 1:2:6 (w/w/w). Within experimental error, both of these particular lipopolyplex mixtures were found to perform identically to pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w) lipopolyplex mixtures (Figure 4 ).
Transfection in differentiated ND7s
The ability of mu-containing lipopolyplex mixtures to transfect differentiated ND7 cells was investigated using pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w) lipopolyplex mixtures, the same as those shown to give optimal transfection in undifferentiated ND7 cells. The ND7 cell line is derived from a fusion of primary rat dorsal root ganglia (DRG) neurons and the mouse neuroblastoma N18Tg2.
30 ND7 cells can be differentiated in a variety of ways including the withdrawal of serum, cAMP administration or exposure to a combination of reduced serum, cAMP and nerve growth factor (NGF). Differentiation of ND7 cells leads to the expression of cellular properties associated with their parental nociceptive sensory neurons including a significant reduction in cell division and the onset of neurite outgrowth. ND7 cells were transfected with lipopolyplex and lipoplex mixtures 24 h after the onset of differentiation. Cells differentiated by all three methods described above were prepared for transfection experiments. Irrespective of the manner in which differentiation was induced, mu-containing lipopolyplex mixtures outperformed lipoplex mixtures by between sixand 10-fold depending upon the manner of differentiation of the ND7 cells ( Figure 5 ). Most crucially, in two out of the three cases, the percentage of differentiated ND7 cells transfected by pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w) lipopolyplex mixtures was equal to if not better than the percentage of undifferentiated ND7 cells transfected with the same mixture ( Figure 5 ).
Discussion
We have previously shown that DC-Chol/DOPE cationic liposomes are efficient at transfecting the neuronally derived ND7 cell line. 29 DC-Chol/DOPE cationic liposomes have been used successfully outside the CNS in a variety of tissues to mediate gene delivery and have undergone clinical trials for gene therapy treatments of cystic fibrosis. 31, 32 Also, DC-Chol/DOPE liposomes have been shown not to exhibit cytotoxic side-effects. 33, 34 For these reasons we have been studying ways to improve upon the efficacy of DC-Chol/DOPE cationic liposomemediated gene delivery for use with neural cells. Since their inception, there has been a continuous drive to develop more and more effective cationic liposome systems, 5, 7 but the vast majority of improvements have been sought by developing new cytofectins such as the successful series of DC-Chol analogues that we recently described. 35 One alternative approach has been to prepare combination delivery systems from cationic liposomes and cationic polymers, using the polymer as an enhancing agent for transfection. [17] [18] [19] [20] [21] In our case, we decided to draw inspiration from the adenovirus in order to try to enhance cationic liposome-mediated gene delivery. In particular, we were drawn to the powerful DNAcondensing peptide, known as (mu), identified in the mature adenovirus core. 27, 28 This 19 amino residue pep-tide results from the cleavage of a 79-residue precursor by adenovirus-encoded proteinase. Mu contains no known nuclear localisation signals but has been reported to have powerful DNA-condensing properties. 27 The condensing power of mu was amply illustrated by our own gel retardation assay data using our test plasmid pCMV␤ (Figure 1) . While a small shift in pCMV␤ (1 g) mobility was observed with a pCMV␤:mu ratio of 1:0.25 (w/w), retardation was essentially complete at a pCMV␤:mu ratio of 1:0.5 (w/w) consistent with almost complete neutralisation of plasmid charge by associated mu (Figure 1) . A simple theoretical calculation is consistent with this observation. A pCMV␤:mu ratio of 1:0.5 (w/w) corresponds to a pCMV␤:mu mole ratio of approximately 1:1000 (assuming an average nucleotide molecular weight of 329). Each pCMV␤ contains 7000 bp that yield a total of 14 000 negative charges per plasmid molecule from all the available phosphodiester links. By contrast, each mu has 12 basic amino acid residues and a free N-terminal ␣-amino functional group that could potentially yield 13 distinct positive charges per peptide molecule. Assuming both the number of potential charges and the pCMV␤:mu mole ratio to be correct, there does indeed appear to be sufficient mu associating with each plasmid to neutralise essentially all of the plasmid negative charges. The Vp1 peptide is the same length as mu and has five basic and one acidic amino acid residues together with a free N-terminal ␣-amino functional group that could potentially yield five distinct positive charges per peptide molecule. However, in spite of being able to present potentially almost half the number of positive charges as mu, Vp1 was found to be a vastly inferior agent for the neutralisation and condensation of pCMV␤ plasmid in comparison to mu (Figure 1 ). This suggests that the nature and order of amino acid residues in a putative nucleic acid binding peptide can have a significant impact upon the charge neutralising and condensing properties of that peptide.
The ability of mu-containing lipopolyplex mixtures to transfect undifferentiated ND7 cells is revealing ( Figures  2, 3 and 4) . The lipopolyplex mixture optimal for transfection, pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w), was found to contain particles of approximately 500-1000 nm in size by photon correlation spectroscopy measurements (unimodal analysis). These particles were certainly positively charged given the excess of mu and cationic liposomes used to prepare them. The pCMV␤:mu:(DCChol/DOPE) 1:12:6 (w/w/w) lipoplex mixture was reproducibly five-fold more effective at mediating ND7 cell transfection in vitro than the best DC-Chol/DOPE lipoplex mixture (pCMV␤:(DC-Chol/DOPE) 1:3 (w/w)), and similar results were also obtained with COS7 cells. Such enhancements are better than we had observed previously in transfection experiments in vitro using our second generation DC-Chol analogue/DOPE cationic liposome systems. 35 Moreover, pCMV␤:mu:(DCChol/DOPE) 1:12:6 (w/w/w) lipopolyplex mixtures proved to be as equally effective at transfecting ND7 cells as lipopolyplex mixtures formulated using poly-l-lysine (pLL) or protamine sulfate (PA) in place of mu. This suggests that mu offers a very real alternative to both as enhancing agents for cationic liposome-mediated transfection and being a very well defined synthetic system could even surpass both given additional experiments.
Lipopolyplex mixtures formulated with Vp1 peptide were singularly unsuccessful in enhancing transfection. This is perhaps unsurprising in view of the weak plasmid charge neutralising and condensing properties of the Vp1 peptide. However, we had hoped for better in view of the classical nuclear localisation signal (NLS) embedded in the sequence (Table 1) . Recent evidence has suggested that nuclear import of nucleic acids may be inefficient during cationic liposome-mediated transfection. 10, 11, 36, 37 For this reason there have been a number of attempts, including the work described here, to improve transfection efficiency by attempting to enhance nuclear uptake of nucleic acids using polycationic polymers harbouring peptide sequences with known nuclear localising capabilities. 17, 20, 22 However, our results appear to suggest that the presence of the NLS sequences does not promote transfection without adequate nucleic acid charge neutralisation and condensation as well. Indeed the latter seems the more important. This is born out by the experience of Fritz et al 22 who observed no difference in transfection efficiencies between recombinant human histone (H1) and a modified version (NLS-H1) containing the SV40 large T antigen nuclear localizing sequence. However, others have suggested that the presence of an NLS does improve the nuclear accumulation of pDNA albeit via specific intracellular pathways. 38, 39 As a specialised adenovirus core peptide, mu may have some influence over these pathways, but that remains to be established.
However, perhaps the most significant observations described here relate to the ability of mu-containing lipopolyplex mixtures to transfect differentiated ND7 cells ( Figure 5 ). Differentiated ND7 cells possess a similar phenotype to their parental peripheral sensory neurons, including the induction of neurite outgrowth, a significant reduction in overall proliferation and a corresponding reduction in transfectability as a result. 30, 35 Hence in effect, differentiated ND7 cells provide a simple ex vivolike post-mitotic CNS cell system. Successful transfection of these cells would bode well for transfection of primary neurons and CNS cells in vivo. Gratifyingly, lipopolyplex mixtures comprised of pCMV␤:mu:(DC-Chol/DOPE) 1:12:6 (w/w/w) were able to transfect differentiated ND7 cells successfully with levels of transfection equivalent to those seen with undifferentiated cells, except in the instance where differentiation was caused by serum withdrawal (− serum) ( Figure 5 ). Moreover, lipopolyplex transfection levels were consistently between six-and 10-fold higher than those seen with transfection by pCMV␤:(DC-Chol/DOPE) 1:3 (w/w) lipoplex mixtures. These results offer a tantalising glimpse that mu may indeed have some influence over the process of nuclear entry of nucleic acids. However, even if that were not the case, mu appears to have some attractive properties that place it alongside pLL and protamine sulfate as a useful enhancer of cationic liposome-mediated gene delivery.
Materials and methods
Cationic peptides and polypeptides pLL (15 000-30 000 kDa) and protamine sulfate were purchased from Sigma (Poole, UK). Peptides Vp1 and Mu were synthesised on a Shimadzu PSSM-8 solid phase peptide synthesiser using a five-fold excess of (9-fluorenyl) methoxycarbonyl (Fmoc)-protected L-amino acids (Novabiochem, Nottingham, UK) and the FastMoc reagents 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetra-methyluronium hexafluorophosphate/hydroxybenzotriazole (HBTU/ HOBt) (Advanced Chemtech Europe, Cambridge, UK) as the amide coupling agent. After resin cleavage and deprotection, desalting was performed by gel filtration using a column of P2 Biogel (2 × 28 cm; BioRad, Herts, UK) attached to an FPLC system (Amersham Pharmacia Biotech UK, Bucks, UK) with 0.1% aqueous TFA as eluant at a flow rate of 0.5-0.75 ml/min. Final preparative reverse-phase purification was achieved with a Vydac column (C18, 5 m, 2 × 25 cm; Hichrom, Berks, UK) attached to a Gilson HPLC system (Anachem, Bedfordshire, UK). Peptides were eluted at 5 ml/min by means of a linear gradient of acetonitrile in 0.1% aqueous TFA and elution monitored at 220-230 nm.
The Vp1 peptide was prepared using a preloaded LPro-2-chlorotrityl super acid labile resin (Novabiochem) (100 mg, 1.05 mmol/g, 0.1 mmol). Extended coupling times were used to incorporate all amino acid residues from the sixth (Lys) through to the N-terminal residue. After automated N-terminal Fmoc deprotection with piperidine (20%, v/v) in dimethyl-formamide, the resin was isolated, washed with dimethylformamide (10 ml) and methanol (15 ml), and then dried in vacuo. Crude peptide was cleaved from the resin using ice cooled TFA (8 ml The mu peptide was prepared using Gly-Wang resin (Novabiochem) (40 mg, 0.67 mmol/g, 0.03 mmol). Normal coupling times were used throughout. After automated N-terminal Fmoc deprotection as above, the resin was isolated and washed with dichloromethane (20 ml) and methanol (20 ml) after which the resin was dried in vacuo. Crude peptide was cleaved from the resin using mixture A (8 ml) and precipitated with MTBE (30 ml), all as above. Finally, the crude peptide mixture was desalted and purified by reverse phase HPLC. After elution, fractions containing the desired peptide (eluting with acetonitrile 17.2%) were combined and lyophilized to give the peptide as a white powder. 
DNA binding analysis
The purified peptides were reconstituted in sterile distilled H 2 O at 3 mg/ml. Peptide and pCMV␤ (1 g) were combined in 20 l HEPES buffered saline (HBS) (137 mm NaCl, 5 mm KCl, 0.75 mm Na 2 HPO 4 , 19 mm HEPES, pH 7.4) for 20 min at room temperature. Peptide:pCMV␤ polyplexes were subsequently analysed by agarose gel electrophoresis (1%). Control incubations for general macromolecular pDNA interactions were performed with varying amounts of molecular biology grade purified bovine serum albumin (Sigma).
Cell cultures ND7 cells are derived from the fusion of a neuroblastoma (N18Tg2) with neonatal rat sensory neurons and are a well-characterised cell line. 30 The cell line was maintained in normal growth media (NGM) (Leibovitz's L-15 media (BRL, Paisley, UK) enriched with 10% fetal bovine serum (BRL), 4 g/l glucose, 4 g/l sodium bicarbonate (BRL), 100 IU/ml penicillin/streptomycin (BRL) at 37°C and 5% CO 2 . The cells were plated on to 24-well plates (Life Technologies, Paisley, UK) at a density (4 × 10 4 cells per well) that produced 70% confluence after 24 h. These cells were then used directly for transfection or differentiated as described below.
Differentiation of ND7 cells was carried out using three methods previously described. 30, 40 Cells were seeded in NGM at a density of 4 × 10 4 cells per well in a 24-well culture dish (Nunc). After 24 h, the media was replaced with either: (a) serum-free differentiation media (− serum) (50% Hams F12, 50% DMEM, 5 g/ml transferrin, 250 ng/ml insulin, 0.3 m sodium selenite); or (b) NGM supplemented with 1 mm adenosine 3Ј,5Ј-cyclic monophosphate (cAMP; Sigma) (cAMP); or (c) low serum nerve growth factor media (NGF) (L-15 supplemented with 2 mm glutamine, 4 g/l glucose, 4 g/l sodium bicarbonate, 100 g/ml penicillin, 100 g/ml streptomycin, 0.5% fetal bovine serum, 1 mm cAMP, 50 ng/ml nerve growth factor (Alomone Laboratories, Jerusalem, Israel). Differentiated ND7 cells were grown in appropriate media for 24 h at 37°C, 5% CO 2 before transfection.
COS-7 cells (derived from Green Monkey kidney) were grown in RPMI 1640 media (BRL) supplemented with 10% fetal bovine serum (BRL) and 100 g/ml penicillin/streptomycin (BRL).
Plasmid constructs
All experiments were performed using the plasmid pCMV␤ (Clontech, Palo Alto, CA, USA) harboring the full-length sequence for E. coli ␤-galactosidase downstream of the human cytomegalovirus immediate-early promoter/enhancer (Clontech, Hampshire, UK). Stocks of plasmid DNA (1 mg/ml) were prepared using standard molecular cloning techniques and purified using the Qiagen Endotoxin-free plasmid purification system (Qiagen, Dorking, UK).
Liposomes DC-Chol/DOPE cationic liposomes were prepared as previously described. 29, 36 Briefly, 6 mol of DC-Chol and 4 mol of DOPE (supplied at 10 mg/ml in CHCl 3 ) were added to freshly distilled CH 2 Cl 2 (5 ml) under nitrogen. 20 mm HEPES buffer, pH 7.8 (5 ml) was added to the mixture and the whole sonicated for 3 min. Organic solvents were removed under reduced pressure and the resulting liposome suspension was then sonicated for a further 3 min. These liposome stock preparations (1.2 mg/ml) were stored at 4°C before use.
Transfection protocol
Since initial experiments determined that the presence of fetal bovine serum inhibited transfection of ND7 cells serum-free differentiation media was used for all transfection experiments. Appropriate aliquots of pCMV␤ (1 l) and cationic liposomes (2.5-5 l) were placed at the bottom of a 7 ml sterile Bijou container (Bibby Sterilin, Staffordshire, UK), but not in contact with each other. DNA and liposomes were combined by the addition of 400 l serum-free differentiation media and gentle shaking. Lipoplex mixtures were then incubated at room temperature for 20 to 30 min before being applied to cells. Lipopolyplex mixtures were generated in the following manner. Peptide (2-7 l) was placed in the bottom of sterile polystyrene containers alongside, but not in contact with pCMV␤ (1 l) and mixed by the introduction of 400 l serum-free NGM media. These polyplex mixtures were then incubated at room temperature for 10 min after which time DC-Chol/DOPE cationic lipsomes (2.5-5 l) were added. Resulting lipopolyplex mixtures were then further incubated at room temperature for 20 min before being applied to cells.
Before transfection, all cells were washed in serum-free media and then exposed to transfection mixtures for 2 h at 37°C, 5% CO 2 . Following this, transfection mixtures were replaced with complete media and incubation continued for 20-24 or 48 h, as appropriate. Thereafter, cells were harvested for ␤-galactosidase enzyme assays (Promega, Southampton, UK) or fixed and processed for X-gal histochemistry as described. 29 Cell counts were made under × 40 magnification using a Nikon Diaphot inverted microscope. Each transfection experiment was repeated at least three times and at least three separate counts were made for each well.
